دانلود و نمایش مقالات مرتبط با Heart failure with preserved ejection fraction::صفحه 1
دانلود بهترین مقالات isi همراه با ترجمه فارسی 2

با سلام خدمت کاربران در صورتی که با خطای سیستم پرداخت بانکی مواجه شدید از طریق کارت به کارت (6037997535328901 بانک ملی ناصر خنجری ) مقاله خود را دریافت کنید (تا مشکل رفع گردد). 

نتیجه جستجو - Heart failure with preserved ejection fraction

تعداد مقالات یافته شده: 1
ردیف عنوان نوع
1 Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big endothelin and patients with heart failure and preserved ejection fraction
عملکرد کلیوی، N ترمینال نرم افزار-B پپتید ناتریورتیک، propeptide اندوتلین بزرگ و بیماران مبتلا به نارسایی قلب و کسر خروجی حفظ-2018
Renal dysfunction may limit the clinical application of NT-proBNP in the diagnosis of heart failure. In general practice, where echocardiography is not readily available, a biomarker for the diagnosis of a heart failure with preserved ejection fraction (HFpEF) would be useful. Since cardiac diseases frequently coincide with renal disease, there is a high need of valid risk stratification methods in patients affected with both. We therefore examined NT-proBNP and another biomarker, Big-Endothelin-1, as a marker of HFpEF in patients with CKD. NT-proBNP and Big-ET-1 were determined in 439 patients with HFpEF in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. NT-proBNP plasma level has shown an exponential increase with declining GFR, while Big-ET-1 plasma level increased only in a moderate and linear fashion. In patients without CKD, a NT-proBNP cut-off point at 250 pg/ mL was suitable for the discrimination between HFpEF and patients without HF. When the GFR was less than 60 mL/min/1.73m2, the NT-proBNP cut-off point should be raised to 750 pg/mL. At a cutoff point at 0.85 fmol/ L, Big-ET-1 allowed to distinguish patients with HFpEF from persons without HF, independently of GFR. In general, NT-proBNP is a good indicator of suspected heart failure. While for NT-proBNP different cut-off points have to be considered in the diagnosis of HFpEF, a single cut-off point of Big-ET-1 was appropriate in the diagnosis of HFpEF, regardless of the presence or absence of CKD. An additional measurement of Big-ET-1 improves the diagnosis of HFpEF in patients with chronic kidney disease.
Keywords: N-Terminal Pro-B-Type natriuretic peptide ، (NT-proBNP)، Big-Endothelin-1 (Big-ET-1) ، Heart failure with preserved ejection fraction ، (HFpEF) ، Chronic kidney disease (CKD) ، Peptides ، Biomarkers
مقاله انگلیسی
rss مقالات ترجمه شده rss مقالات انگلیسی rss کتاب های انگلیسی rss مقالات آموزشی
logo-samandehi
بازدید امروز: 1645 :::::::: بازدید دیروز: 0 :::::::: بازدید کل: 1645 :::::::: افراد آنلاین: 65